Background: Studies of fertility in men treated for testicular cancer have mainly addressed
serum follicle-stimulating hormone levels and sperm parameters. We assessed post-treatment …

Germ-cell testicular cancer (TC) represents a malignancy with very high cure rates. After the
introduction of cisplatin-based chemotherapy in the late 1970s, the 5-year survival rate has …

Background Sensory neuropathy (paresthesias), tinnitus, hearing impairment, and Raynaud
phenomena are side effects of cisplatin-based chemotherapy used to treat testicular cancer …

Gonadal dysfunction and fertility problems are adverse effects of cancer treatment or may be
associated with specific malignancies. This review focuses on these problems in the young …

Background To assess the impact of polymorphisms in Glutathione S-transferase (GST) -P1,
-M1, and -T1 on self-reported chemotherapy-induced long-term toxicities in testicular cancer …

In male cancer patients, surgery, radiotherapy and chemotherapy can be followed by
transient or permanent infertility by affecting ejaculatory or erectile function, or by impairing …

… Brydøy et al7 assessed the chance of paternity among 554 TCSs who participated at SI
and had attempted fatherhood. The 15-year actuarial post-treatment paternity rate varied from …

BACKGROUND: Preserved fertility is an important issue for testicular cancer (TC) survivors.
OBJECTIVE: Our aim was to examine any difference regarding paternity and testicular …

Results Median observation time was 11.2 years (range, 5 to 21 years). Compared with the
surgery group, the higher-dose or cis/pulmsurg groups had considerably lower age-adjusted …

MicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular
germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-…